The Need for Continuous Requalification and Support of Cell and Gene Therapy Distribution

The Need for Continuous Requalification and Support of Cell and Gene Therapy Distribution

Tuesday, March 19, 2024 9:10 AM to 9:30 AM · 20 min. (Europe/London)
Keynote [Track 1]
Presentation

Information

In light of the recent FDA disclosure of contamination risks associated with cell therapy manufacturing, the industry needs to revisit the need for continuous requalification of both the performance of equipment and processes as well as the transportation and distribution.

Log in